https://www.selleckchem.com/Androgen-Receptor.html
Our simulations indicate that a 70% reduction (51/17 in diagnostic centres still exceeded minimal targets of coverage even for remote populations, with 95% of a total PAR of ~3million individuals living ≤1h from a diagnostic centre, and we demonstrate an approach to best place these facilities, informing a minimal impact scale back. Our results highlight that surveillance of g-HAT in north-western Uganda can be scaled back without substantially reducing coverage of the PAR. The methodology described can contribute to cost-effecti